TrialClinical cancer research : an official journal of the American Association for Cancer Research2009

A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu.

Prema P Peethambaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.